Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.1955
Nov 20 • 4:00 PM ET Dollar change-0.1045 Percentage change(-34.83%)
Aftermarket Close
0.1830
Aftermarket • 7:59 PM ET Dollar change-0.0125 Percentage change(-6.39%)
Nov 20, 10:02 AMSEC F-3 effectiveness for 77 million resale shares sinks SPRC 30% early
Index
-
Market Cap
0.40M
Enterprise Value
5.95M
Income
-8.22M
Sales
0.68M
Book/sh
6.79
Cash/sh
2.18
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
3
IPO
Aug 30, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
0.59
P/B
0.03
P/C
0.09
P/FCF
-
EV/EBITDA
-
EV/Sales
8.75
Quick Ratio
0.86
Current Ratio
0.87
Debt/Eq
0.68
LT Debt/Eq
0.00
Option/Short
No / No
EPS (ttm)
-79.46
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
31.81% -13.87%
Sales past 3/5Y
-14.03% -
EPS Y/Y TTM
62.32%
Sales Y/Y TTM
-26.75%
EPS Q/Q
-
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
1.85%
Insider Trans
-1.19%
Inst Own
1.45%
Inst Trans
3.24%
ROA
-69.59%
ROE
-519.89%
ROIC
-208.42%
Gross Margin
51.25%
Oper. Margin
-660.53%
Profit Margin
-1210.90%
SMA20
-61.83%
SMA50
-92.23%
SMA200
-96.11%
Trades
Shs Outstand
2.06M
Shs Float
2.02M
52W High
29.88 -99.35%
52W Low
0.23 -14.16%
Volatility
38.19% 23.07%
ATR (14)
0.19
RSI (14)
15.22
Beta
2.82
Rel Volume
1.66
Avg Volume
2.82M
Volume
4,661,245
Perf Week
-44.63%
Perf Month
-83.71%
Perf Quarter
-97.06%
Perf Half Y
-95.42%
Perf YTD
-98.40%
Perf Year
-99.08%
Perf 3Y
-99.98%
Perf 5Y
-100.00%
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
0.30
Price
0.20
Change %
-34.83%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SMITH JAMES EDMOND10% OwnerJun 22 '26Proposed Sale7.9073,909583,881Jun 22 01:46 PM
Shrem ItschakDirectorJun 01 '26Sale10.004624,62010,596Jun 03 08:00 AM
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. It operates through the Drug Development and Online Sales segments. The Drug Development segment focuses on cannabinoid molecules to be approved by an official regulatory authority. The Online Sales segment consists of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.
CEO & CFOMr. Oz Adler CPA
President & DirectorMr. Amitai Weiss
Chief Technologies OfficerDr. Adi Zuloff-Shani Ph.D.